AF267
Code | Size | Price |
---|
TAR-T25005-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T25005-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T25005-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
AF267 is a M1 muscarinic agonist that works by restoring cognitive impairments.
CAS:
168818-83-5
Formula:
C10H18N2OS
Molecular Weight:
214.33
Purity:
0.98
SMILES:
CCC1SC2(CCN(C)CC2)NC1=O
References
1. Svingen GFT, Zuo H, Ueland PM, Seifert R, L?land KH, Pedersen ER, Schuster PM, Karlsson T, Tell GS, Schartum-Hansen H, Olset H, Svenningsson M, Strand E, Nilsen DW, Nordrehaug JE, Dhar I, Nyg?rd O. Increased plasma trimethylamine-N-oxide is associated with incident atrial fibrillation. Int J Cardiol. 2018 Sep 15;267:100-106. doi: 10.1016/j.ijcard.2018.04.128. PubMed PMID: 29957250.
2. Trakman GL, Forsyth A, Hoye R, Belski R. Development and validation of a brief general and sports nutrition knowledge questionnaire and assessment of athletes' nutrition knowledge. J Int Soc Sports Nutr. 2018 Apr 19;15:17. doi: 10.1186/s12970-018-0223-1. eCollection 2018. PubMed PMID: 29713248; PubMed Central PMCID: PMC5907737.
3. Hoskins MH, Patel AM, DeLurgio DB. Left Atrial Appendage Occlusion, Shared Decision-Making, and Comprehensive Atrial Fibrillation Management. Interv Cardiol Clin. 2018 Apr;7(2):267-283. doi: 10.1016/j.iccl.2017.12.006. Review. PubMed PMID: 29526294.
4. Yoshida T, Uchino S, Yokota T, Fujii T, Uezono S, Takinami M. The impact of sustained new-onset atrial fibrillation on mortality and stroke incidence in critically ill patients: A retrospective cohort study. J Crit Care. 2018 Apr;44:267-272. doi: 10.1016/j.jcrc.2017.11.040. Epub 2017 Dec 1. PubMed PMID: 29220756.